1152 related articles for article (PubMed ID: 26718510)
21. Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial.
Pibarot P; Ternacle J; Jaber WA; Salaun E; Dahou A; Asch FM; Weissman NJ; Rodriguez L; Xu K; Annabi MS; Guzzetti E; Beaudoin J; Bernier M; Leipsic J; Blanke P; Clavel MA; Rogers E; Alu MC; Douglas PS; Makkar R; Miller DC; Kapadia SR; Mack MJ; Webb JG; Kodali SK; Smith CR; Herrmann HC; Thourani VH; Leon MB; Hahn RT;
J Am Coll Cardiol; 2020 Oct; 76(16):1830-1843. PubMed ID: 33059828
[TBL] [Abstract][Full Text] [Related]
22. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial.
Abdel-Wahab M; Mehilli J; Frerker C; Neumann FJ; Kurz T; Tölg R; Zachow D; Guerra E; Massberg S; Schäfer U; El-Mawardy M; Richardt G;
JAMA; 2014 Apr; 311(15):1503-14. PubMed ID: 24682026
[TBL] [Abstract][Full Text] [Related]
23. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.
Kapadia SR; Leon MB; Makkar RR; Tuzcu EM; Svensson LG; Kodali S; Webb JG; Mack MJ; Douglas PS; Thourani VH; Babaliaros VC; Herrmann HC; Szeto WY; Pichard AD; Williams MR; Fontana GP; Miller DC; Anderson WN; Akin JJ; Davidson MJ; Smith CR;
Lancet; 2015 Jun; 385(9986):2485-91. PubMed ID: 25788231
[TBL] [Abstract][Full Text] [Related]
24. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
[TBL] [Abstract][Full Text] [Related]
25. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk.
Baron SJ; Wang K; House JA; Magnuson EA; Reynolds MR; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Mack MJ; Brown DL; Russo MJ; Smith CR; Webb J; Miller C; Leon MB; Cohen DJ
Circulation; 2019 Feb; 139(7):877-888. PubMed ID: 30586747
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry.
Tarantini G; Mojoli M; Windecker S; Wendler O; Lefèvre T; Saia F; Walther T; Rubino P; Bartorelli AL; Napodano M; D'Onofrio A; Gerosa G; Iliceto S; Vahanian A
JACC Cardiovasc Interv; 2016 May; 9(9):937-46. PubMed ID: 27085579
[TBL] [Abstract][Full Text] [Related]
27. 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial.
Abdel-Wahab M; Landt M; Neumann FJ; Massberg S; Frerker C; Kurz T; Kaur J; Toelg R; Sachse S; Jochheim D; Schäfer U; El-Mawardy M; Robinson DR; Richardt G;
JACC Cardiovasc Interv; 2020 May; 13(9):1071-1082. PubMed ID: 32305398
[TBL] [Abstract][Full Text] [Related]
28. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
29. Transcatheter aortic valve implantation with the new balloon-expandable Sapien 3 versus Sapien XT valve system: a propensity score-matched single-center comparison.
Nijhoff F; Abawi M; Agostoni P; Ramjankhan FZ; Doevendans PA; Stella PR
Circ Cardiovasc Interv; 2015 Jun; 8(6):e002408. PubMed ID: 26033967
[TBL] [Abstract][Full Text] [Related]
30. New generation devices for transfemoral transcatheter aortic valve replacement are superior compared with last generation devices with respect to VARC-2 outcome.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Cardiovasc Interv Ther; 2018 Jul; 33(3):247-255. PubMed ID: 28643214
[TBL] [Abstract][Full Text] [Related]
31. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy.
Blackstone EH; Suri RM; Rajeswaran J; Babaliaros V; Douglas PS; Fearon WF; Miller DC; Hahn RT; Kapadia S; Kirtane AJ; Kodali SK; Mack M; Szeto WY; Thourani VH; Tuzcu EM; Williams MR; Akin JJ; Leon MB; Svensson LG
Circulation; 2015 Jun; 131(22):1989-2000. PubMed ID: 25832034
[TBL] [Abstract][Full Text] [Related]
32. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
Williams M; Kodali SK; Hahn RT; Humphries KH; Nkomo VT; Cohen DJ; Douglas PS; Mack M; McAndrew TC; Svensson L; Thourani VH; Tuzcu EM; Weissman NJ; Kirtane AJ; Leon MB
J Am Coll Cardiol; 2014 Apr; 63(15):1522-8. PubMed ID: 24561149
[TBL] [Abstract][Full Text] [Related]
33. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve.
Mussardo M; Latib A; Chieffo A; Godino C; Ielasi A; Cioni M; Takagi K; Davidavicius G; Montorfano M; Maisano F; Carlino M; Franco A; Covello RD; Spagnolo P; Grimaldi A; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2011 Jul; 4(7):743-50. PubMed ID: 21777881
[TBL] [Abstract][Full Text] [Related]
34. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
Eltchaninoff H; Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A
Arch Cardiovasc Dis; 2012 Mar; 105(3):132-40. PubMed ID: 22520795
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
Dvir D; Waksman R; Barbash IM; Kodali SK; Svensson LG; Tuzcu EM; Xu K; Minha S; Alu MC; Szeto WY; Thourani VH; Makkar R; Kapadia S; Satler LF; Webb JG; Leon MB; Pichard AD
J Am Coll Cardiol; 2014 Jan; 63(3):269-79. PubMed ID: 24140659
[TBL] [Abstract][Full Text] [Related]
36. Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valves II inoperable cohort.
Lindman BR; Maniar HS; Jaber WA; Lerakis S; Mack MJ; Suri RM; Thourani VH; Babaliaros V; Kereiakes DJ; Whisenant B; Miller DC; Tuzcu EM; Svensson LG; Xu K; Doshi D; Leon MB; Zajarias A
Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25855679
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement Compared With Surgical Valve Replacement in Intermediate-Risk Patients.
Madhavan MV; Kodali SK; Thourani VH; Makkar R; Mack MJ; Kapadia S; Webb JG; Cohen DJ; Herrmann HC; Williams M; Greason K; Pibarot P; Hahn RT; Jaber W; Xu K; Alu M; Smith CR; Leon MB
J Am Coll Cardiol; 2023 Jul; 82(2):109-123. PubMed ID: 37407110
[TBL] [Abstract][Full Text] [Related]
38. The SAPIEN 3 valve: lights and shadows.
Facchin M; Mojoli M; Covolo E; Tarantini G
Minerva Med; 2014 Dec; 105(6):497-500. PubMed ID: 25283260
[TBL] [Abstract][Full Text] [Related]
39. Complications after Transfemoral Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prosthesis: The Importance of Preventative Measures and Contingency Planning.
Chakravarty T; Jilaihawi H; Doctor N; Fontana G; Forrester JS; Cheng W; Makkar R
Catheter Cardiovasc Interv; 2018 Apr; 91(5):E29-E42. PubMed ID: 23436313
[TBL] [Abstract][Full Text] [Related]
40. Sutureless versus transcatheter aortic valves in elderly patients with aortic stenosis at intermediate risk: A multi-institutional study.
Muneretto C; Solinas M; Folliguet T; Di Bartolomeo R; Repossini A; Laborde F; Rambaldini M; Santarpino G; Di Bacco L; Fischlein T
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):925-935.e5. PubMed ID: 32727681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
